Stasilon: Difference between revisions

From Wikipedia, the free encyclopedia
Content deleted Content added
BG19bot (talk | contribs)
m Add DEFAULTSORT using AWB (8853)
10.1186/1752-1947-4-20
Line 11: Line 11:
{{cite journal
{{cite journal
|title=Use of the novel hemostatic textile Stasilon® to arrest refractory retroperitoneal hemorrhage: a case report
|title=Use of the novel hemostatic textile Stasilon® to arrest refractory retroperitoneal hemorrhage: a case report
|url=http://www.doaj.org/doaj?func=abstract&id=516135
|last1=Rich|first1=Preston
|last1=Rich|first1=Preston
|last2=Douillet|first2=Christelle
|last2=Douillet|first2=Christelle
Line 19: Line 18:
|last6=Cairns|first6=Bruce
|last6=Cairns|first6=Bruce
|journal=Journal of Medical Case Reports
|journal=Journal of Medical Case Reports
|issn=17521947
|year=2010
|year=2010
|volume=4
|volume=4
|doi=10.1186/1752-1947-4-20
|number=1}}</ref><ref>
|number=1}}</ref><ref>
{{cite journal
{{cite journal

Revision as of 09:19, 30 September 2014

Stasilon is a brand-name hemostatic woven textile manufactured by Entegrion, Inc. of Durham, North Carolina. It is made from fibers of continuous filament fiberglass and bamboo yarn and used to accelerate clotting and stop bleeding from cuts and abrasions. Originally intended for military use, NATO and United States Navy reviews have reported its abilities to be unsuited to life-threatening arterial hemorrhaging.[1][2] But Stasilon is finding use in operating and burn victim treatment settings.[3][4]

Entegrion received FDA approval to market their fabric in 2007.[5]

References

  1. ^ Dubick, Michael A. New Technologies for Treating Severe Bleeding in Far-Forward Combat Areas (Report). NATO Research and Technology Organization. RTO-MP-HFM-182. Retrieved 20 January 2011. {{cite report}}: Unknown parameter |coauthors= ignored (|author= suggested) (help)
  2. ^ Hemostatic Agent Development - Navy SBIR
  3. ^ Rich, Preston; Douillet, Christelle; Buchholz, Valorie; Overby, David; Jones, Samuel; Cairns, Bruce (2010). "Use of the novel hemostatic textile Stasilon® to arrest refractory retroperitoneal hemorrhage: a case report". Journal of Medical Case Reports. 4 (1). doi:10.1186/1752-1947-4-20.{{cite journal}}: CS1 maint: unflagged free DOI (link)
  4. ^ Vinluan, Frank (2 November 2009). "Entegrion seeks $4M to jump-start sales". Triangle Business Journal.
  5. ^ "December 2007 510(k) Clearances".